GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Nutex Health Inc (NAS:NUTX) » Definitions » Days Sales Outstanding

Nutex Health (Nutex Health) Days Sales Outstanding : 76.93 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Nutex Health Days Sales Outstanding?

Nutex Health's average Accounts Receivable for the three months ended in Dec. 2023 was $58.7 Mil. Nutex Health's Revenue for the three months ended in Dec. 2023 was $69.7 Mil. Hence, Nutex Health's Days Sales Outstanding for the three months ended in Dec. 2023 was 76.93.

The historical rank and industry rank for Nutex Health's Days Sales Outstanding or its related term are showing as below:

NUTX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 82.34   Med: 122.7   Max: 144.04
Current: 82.34

During the past 5 years, Nutex Health's highest Days Sales Outstanding was 144.04. The lowest was 82.34. And the median was 122.70.

NUTX's Days Sales Outstanding is ranked worse than
79.75% of 637 companies
in the Healthcare Providers & Services industry
Industry Median: 46.01 vs NUTX: 82.34

Nutex Health's Days Sales Outstanding declined from Dec. 2022 (103.30) to Dec. 2023 (76.93).


Nutex Health Days Sales Outstanding Historical Data

The historical data trend for Nutex Health's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutex Health Days Sales Outstanding Chart

Nutex Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
135.91 96.09 122.70 144.04 89.24

Nutex Health Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.30 88.96 80.16 77.62 76.93

Competitive Comparison of Nutex Health's Days Sales Outstanding

For the Health Information Services subindustry, Nutex Health's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutex Health's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Nutex Health's Days Sales Outstanding falls into.



Nutex Health Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Nutex Health's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (58.316 + 62.776) / 2 ) / 247.646*365
=60.546 / 247.646*365
=89.24

Nutex Health's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (54.697 + 62.776) / 2 ) / 69.669*365 / 4
=58.7365 / 69.669*365 / 4
=76.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nutex Health  (NAS:NUTX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Nutex Health Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Nutex Health's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutex Health (Nutex Health) Business Description

Traded in Other Exchanges
N/A
Address
6030 S. Rice Ave, Suite C, Houston, TX, USA, 77081
Nutex Health Inc is healthcare services and operations company with 19 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Executives
Thomas T. Vo director, officer: Chairman, CEO 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Joshua Detillio officer: Chief Operating Officer 6030 S. RICE AVENUE, SUITE C, HOUSTON TX 77081
Jon Christian Bates officer: Chief Financial Officer 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Mitchell Creem director 700 NORTH BRAND BLVD., SUITE 450, GLENDALE CA 91203
Pamela W. Montgomery officer: Chief Legal Off. & Secretary 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Michael Lee Reed director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
Cheryl Yvonne Grenas director 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081
John J Waters director 2165 TECHNOLOGY DRIVE, SCHENECTADY NY 12308
Danniel Stites director 3050 S. DOBSON ROAD, CHANDLER AZ 85248
Premier Macy Management Holdings, Llc 10 percent owner 2819 CYPRESS DRIVE, TEXARKANA TX 75503
Michael Bowen officer: Chief Financial Officer 501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701
Warren Hosseinion director C/O 1668 S. GARFIELD AVENUE, 2ND FLOOR, ALHAMBRA CA 91801
Lawrence Schimmel officer: Chief Medical Information Off 5193 SW 75TH STREET, MIAMI FL 33143
Frederick Sternberg officer: President of subsidiary 10772 SANDY RUN RD, JUPTIER FL 33478
Micro Hospital Holding Llc 10 percent owner 6030 S. RICE AVE., SUITE C, HOUSTON TX 77081